Regeneron (REGN): Cutting Estimates On Praluent Injunction - Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Jefferies Cuts Price Target on Regeneron (REGN) Following District Court Ruling
January 6, 2017 9:28 AM ESTJefferies maintained a Hold rating on Regeneron Pharma (NASDAQ: REGN), and cut the price target to $349.00 (from $394.00), following a decision by the District Court of Delaware. Judge Sue Robinson at the District Court of Delaware ruled in favor of Amgen (NASDAQ:... More
Regeneron (REGN) Falls 8% as Trading Resumes
January 6, 2017 7:12 AM ESTRegeneron (NASDAQ: REGN) is down 7.9% as trading resumes.
... MoreRegeneron (REGN) set to resume trading at 07:10AM ET following negative ruling
January 6, 2017 6:41 AM ESTRegeneron (NASDAQ: REGN) is set to resume trading at 07:10AM ET following negative ruling.
... More